Middelkamp Vera, Kekäläinen Eliisa
Translational Immunology Research Program and Dept. of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Geroscience. 2025 Feb 13. doi: 10.1007/s11357-025-01555-3.
Age-associated thymic involution leads to a significant decline in thymic T cell output, a major contributor to immunosenescence in the elderly. Accurately measuring thymic output is therefore critical for understanding the mechanisms behind immune aging. Furthermore, robust quantification of thymic output is essential in various other clinical and research settings, including the diagnosis of immunodeficiencies and the monitoring of T cell reconstitution following therapeutic interventions like hematopoietic stem cell transplantation. Current methodologies for measuring thymic output include T cell receptor excision circle (TREC) quantification via quantitative polymerase chain reaction and the enumeration of recent thymic emigrants (RTEs) using flow cytometry. However, TREC-based assays are inherently insensitive to subtle changes in thymic output, limiting their applicability beyond neonatal immunodeficiency screening. Similarly, RTE enumeration presents challenges; while surface markers exist for CD4⁺ RTEs, validated markers for CD8⁺ cytotoxic T lymphocytes are lacking. This represents a significant knowledge gap, particularly as aging has been shown to disproportionally affect the CD8 T cell pool. Moreover, while flow cytometry effectively measures mature naïve T cells, these cells do not accurately represent real-time thymic output, as they can persist in peripheral circulation for extended periods. These limitations highlight the pressing need for more accurate and sensitive methods to assess thymic output. Improved measurement techniques would not only enhance our understanding of thymic involution in the context of aging but also enable large-scale investigations into thymic function and the mechanisms driving its decline in both health and disease. In this review, we examine current methodologies for measuring thymic output in humans, critically evaluate their limitations, and discuss emerging approaches to address these gaps in the field.
与年龄相关的胸腺退化导致胸腺T细胞输出显著下降,这是老年人免疫衰老的主要原因。因此,准确测量胸腺输出对于理解免疫衰老背后的机制至关重要。此外,在各种其他临床和研究环境中,包括免疫缺陷的诊断以及造血干细胞移植等治疗干预后T细胞重建的监测,对胸腺输出进行可靠量化也至关重要。目前测量胸腺输出的方法包括通过定量聚合酶链反应进行T细胞受体切除环(TREC)定量,以及使用流式细胞术对近期胸腺迁出细胞(RTE)进行计数。然而,基于TREC的检测方法对胸腺输出的细微变化本质上不敏感,限制了它们在新生儿免疫缺陷筛查之外的适用性。同样,RTE计数也存在挑战;虽然存在针对CD4⁺RTE的表面标志物,但缺乏用于CD8⁺细胞毒性T淋巴细胞的经过验证的标志物。这代表了一个重大的知识空白,特别是因为衰老已被证明对CD8 T细胞库的影响不成比例。此外,虽然流式细胞术有效地测量成熟的初始T细胞,但这些细胞不能准确代表实时胸腺输出,因为它们可以在外周循环中持续很长时间。这些局限性凸显了对更准确、更敏感的胸腺输出评估方法的迫切需求。改进的测量技术不仅能增强我们对衰老背景下胸腺退化的理解,还能使我们大规模研究胸腺功能以及在健康和疾病状态下驱动其衰退的机制。在这篇综述中,我们研究了目前用于测量人类胸腺输出的方法,批判性地评估了它们的局限性,并讨论了弥补该领域这些差距的新方法。